Translating Computational Models into a More Predictable Patient Outcome for Structural Heart Interventions
by Prof. Dr. Ir. Matthieu De Beule
With every patient’s anatomy being unique, the outcome of structural heart interventions depends heavily on the interaction between the device and that specific patient. As a leader in personalized computational modeling and simulation for trans-catheter structural heart interventions, FEops applies routine preoperative imaging data to predict the device position and deformation.
With their CE-marked TAVI guide, which allows to predict serious complications such as PVL and conduction abnormalities, FEops brings science to procedure planning as opposed to traditional measuring on anatomy. A methodology that will certainly add value to TAVI in treating complex anatomies such as patients with bicuspid aortic valves and TMVR as the mitral valve is much more complex in anatomy and fysiology than the aortic valve.
Today, CEO and co-founder of FEops Dr. Ir. Matthieu De Beule will talk about how computational modelling and simulation can give medical device companies the opportunity to integrate valve design with patient-specific testing, and to do so virtually, cost-effectively and in a clinically meaningful way.
About the speaker
Prior to co-founding FEops, Prof. Dr. Ir. De Beule completed his degree in Engineering at Ghent University in 2002 and gained his Ph.D. in 2008 for his research on cardiovascular device and procedure modeling.
Materialise medical device software may not be available in all markets because product availability is subject to the regulatory and/ or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics and/or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.
This content is intended for Health Care Professionals only.